Cortez et al., 2016 - Google Patents
Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxideCortez et al., 2016
- Document ID
- 15100640171205973294
- Author
- Cortez A
- Li Y
- Miller A
- Zhang X
- Yue K
- Maginnis J
- Hampton J
- Hall D
- Shapiro M
- Nayak B
- D’Oro U
- Li C
- Skibinski D
- Mbow M
- Singh M
- O’Hagan D
- Cooke M
- Valiante N
- Wu T
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Small molecule Toll-like receptor 7 (TLR7) agonists have been used as vaccine adjuvants by enhancing innate immune activation to afford better adaptive response. Localized TLR7 agonists without systemic exposure can afford good adjuvanticity, suggesting peripheral …
- 108010060825 Toll-Like Receptor 7 0 title abstract description 107
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cortez et al. | Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxide | |
| Federico et al. | Modulation of the innate immune response by targeting toll-like receptors: a perspective on their agonists and antagonists | |
| Shae et al. | Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines | |
| Li et al. | Mimetic heat shock protein mediated immune process to enhance cancer immunotherapy | |
| Tom et al. | Modulation of innate immune responses via covalently linked TLR agonists | |
| Dowling et al. | Toll‐like receptors: the swiss army knife of immunity and vaccine development | |
| Wu et al. | Rational design of small molecules as vaccine adjuvants | |
| Verbeke et al. | Broadening the message: a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells | |
| Romagne | Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors | |
| Krieg | CpG still rocks! Update on an accidental drug | |
| Melief et al. | Therapeutic cancer vaccines | |
| Desmet et al. | Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination | |
| Mbow et al. | New adjuvants for human vaccines | |
| Zom et al. | TLR ligand–peptide conjugate vaccines: toward clinical application | |
| Zheng et al. | γδ-T cells: an unpolished sword in human anti-infection immunity | |
| Dubensky Jr et al. | Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants | |
| Kokatla et al. | Exquisite selectivity for human toll-like receptor 8 in substituted furo [2, 3-c] quinolines | |
| Vasievich et al. | Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model | |
| Francica et al. | Thermoresponsive polymer nanoparticles co-deliver RSV F trimers with a TLR-7/8 adjuvant | |
| Rajput et al. | Dendritic cell-targeted nanovaccine delivery system prepared with an immune-active polymer | |
| Andrews et al. | Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity | |
| Foust et al. | Mixed aryl phosphonate prodrugs of a butyrophilin ligand | |
| Andrianov et al. | Molecular-level interactions of polyphosphazene immunoadjuvants and their potential role in antigen presentation and cell stimulation | |
| Davey et al. | Synthesis and biological evaluation of (E)-4-hydroxy-3-methylbut-2-enyl phosphate (HMBP) aryloxy triester phosphoramidate prodrugs as activators of Vγ9/Vδ2 T-cell immune responses | |
| Salunke et al. | Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants |